Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination

Anti-SARS-CoV-2 vaccines were developed in response to the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although the BNT162b2 mRNA vaccine is effective, adverse effects have been reported. Here, we report a case of extranodal NK...

Descripción completa

Detalles Bibliográficos
Autores principales: Tachita, Takuto, Takahata, Takenori, Yamashita, Satoru, Ebina, Toru, Kamata, Kosuke, Yamagata, Kazufumi, Tamai, Yoshiko, Sakuraba, Hirotake
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124685/
https://www.ncbi.nlm.nih.gov/pubmed/37093551
http://dx.doi.org/10.1007/s12185-023-03607-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124685/
https://www.ncbi.nlm.nih.gov/pubmed/37093551
http://dx.doi.org/10.1007/s12185-023-03607-w

Ejemplares similares